Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia
Clinical trial NCT07458542 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07458542
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-09
- Primary completion
- 2026-01-09
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.